NCT05944744View on ClinicalTrials.gov

The Role of Cobamamide Supplements in Malnourished Patients

NAUnknownINTERVENTIONAL

Enrollment

124

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

July 31, 2024

Study Completion Date

August 31, 2024

Conditions

Malnutrition

Interventions

DRUG

Adenosylcobalamin

The drug contains Cobamamide / Adenosylcobalamin with dose of 3000 mg.

DRUG

Placebo

The drug doesn't contain any properties or substances for treatment.

Sponsors

Collaborators (1)

Interbat Pharmaceuticals

All Listed Sponsors

collaborator

Interbat Pharmaceuticals

UNKNOWN

lead

Fakultas Kedokteran Universitas Indonesia

OTHER